🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07518680
Starting soon Not applicable

A Clinical Study on the Effect of Massaging Tian Tu Acupoint on Coughing After Esophageal Surgery

NCT07518680 · tracked via the Priya Life Science China tracker
Sponsor
Shanghai Zhongshan Hospital
Phase
Not applicable
Started
2026-04-10
Last updated
2026-04-08

Condition(s) studied

Esophageal Neoplasms

Investigational drug(s) / intervention(s)

Pressing the Tiantu acupoint to stimulate coughing

Pressing the Tiantu acupoint to stimulate coughing: At the end of inhalation, press the Tiantu acupoint to stimulate coughing. The specific operation method has been mentioned earlier.

Study summary

This study is a single-center, self-controlled trial. Patients will successively undergo voluntary coughing without intervention, a washout period, coughing stimulated by pressing the Tiantu acupoint, a washout period, and voluntary coughing without intervention. Vital signs of the patients before and after each cough will be recorded, as well as the changes in peak cough flow rate and intra-abdominal pressure after each cough. For peak cough flow rate and intra-abdominal pressure, three sets of data will be collected each time, and the best value will be taken. This pilot trial is conducted to verify the feasibility of the research design and to provide sample size estimation and data support for the main study.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: 1. Voluntarily sign the informed consent form and follow the requirements of the protocol; 2. Age 18 to 75 years old (inclusive), gender not limited; 3. Patients who have undergone esophageal surgery (without intubation); 4. Not taking psychotropic drugs, mentally sound, and likely to cooperate in completing the assessment and intervention. Exclusion Criteria: 1. The subjects or their family members request to withdraw from the study; 2. Pregnancy or lactation period; 3. Severe heart and lung diseases (such as heart failure, acute exacerbation of COPD, asthma, etc.); 4. Skin damage or infection in the area of the Tiantu acupoint; 5. Within the last month, have received other cough-related interventions (such as acupuncture, physical therapy); 6. Other situations that the researcher deems unsuitable for participating in this clinical trial

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Zhongshan Hospital Shanghai Shanghai Municipality

More Shanghai Zhongshan Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07518680 on ClinicalTrials.gov ↗ ← All trials in China